Cargando…
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
Due to the rapid, vast, and emerging global spread of the Coronavirus Disease 2019 (COVID-19) pandemic, many drugs were quickly repurposed in a desperate attempt to unveil a miracle drug. Ivermectin (IVM), an antiparasitic macrocyclic lactone, was tested and confirmed for its in vitro antiviral acti...
Autores principales: | Awad, Hoda, Hassan, Basmala, Dweek, Sara, Aboelata, Yasmeen, Rawas-Qalaji, Mutasem, Ahmed, Iman Saad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506580/ https://www.ncbi.nlm.nih.gov/pubmed/36145289 http://dx.doi.org/10.3390/ph15091068 |
Ejemplares similares
-
Formulation and optimization of ivermectin nanocrystals for enhanced topical delivery
por: Awad, Hoda, et al.
Publicado: (2023) -
Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE
por: Al Ali, Lamia, et al.
Publicado: (2022) -
Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use
por: Rachid, Ousama, et al.
Publicado: (2018) -
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
por: Tang, Mingyang, et al.
Publicado: (2021) -
A Review on Current COVID-19 Vaccines and Evaluation of Particulate Vaccine Delivery Systems
por: Shah, Sarthak M., et al.
Publicado: (2021)